Curocell Inc
KOSDAQ:372320
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Curocell Inc
KOSDAQ:372320
|
KR |
|
T
|
Tower Semiconductor Ltd
F:TOW
|
IL |
|
M
|
Minor International PCL
SET:MINT
|
TH |
|
M
|
Mukdahan International Hospital PCL
SET:HANN
|
TH |
|
W
|
Wendel SE
F:WIS
|
FR |
|
K
|
King Gen PCL
SET:KGEN
|
TH |
|
HusCompagniet A/S
CSE:HUSCO
|
DK |
|
Bank Negara Indonesia (Persero) Tbk PT
IDX:BBNI
|
ID |
|
D
|
DT&CRO Co Ltd
KOSDAQ:383930
|
KR |
|
G
|
G-Able PCL
SET:GABLE
|
TH |
|
C
|
CTS Eventim AG & Co KgaA
XMUN:EVD
|
DE |
|
B
|
Ball Corp
DUS:BL8
|
US |
|
K
|
KC Property PCL
SET:KC
|
TH |
|
Musashi Seimitsu Industry Co Ltd
F:67X
|
JP |
|
B
|
BBGI PCL
SET:BBGI
|
TH |
|
T
|
Traction Uranium Corp
F:Z1K
|
CA |
|
A
|
Arinsiri Land PCL
SET:ARIN
|
TH |
|
S
|
Strategic Partners A/S
OTC:OZYMF
|
DK |
Intrinsic Value
Is Curocell Inc undervalued or overvalued?
See the intrinsic value estimate for Curocell Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Curocell Inc looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Curocell Inc’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Curocell Does
Curocell is a South Korean biotech company focused on cell therapies, especially CAR-T treatments that reprogram a patient’s own immune cells to fight cancer. Its main work is developing these therapies for blood cancers and other hard-to-treat diseases, then taking them through clinical testing and regulatory review. The company is not a drug distributor or hospital provider; it is a drug developer that turns lab science into treatment candidates.
- Headquarters
- Korea KR
- Employees
- 136
- IPO date
- Nov 9, 2023
Earnings Waterfall
Curocell Inc
The intrinsic value for Curocell Inc (372320) under the Base Case is hidden KRW.
Compared with the current market price of 22 750 KRW, the stock appears hidden.